Dr. Vreeke is a cofounder of the Chemical Angel Network. The Chemical Angel Network provides a source of capital for early stage firms that converge with the chemical sector in the materials, measurement and manufacturing space.
Previously, Dr. Vreeke served as vice president of R&D for Rational Biotechnology, a Rational Systems spin-off. Rational Biotech’s mission was to speed the adoption of personalized medicine through the development of combined IVD and drug therapy products. Rational Biotech identified a novel route to the delivery of personalized therapy without the requirement of massive clinical trials. He also served as the Senior VP of R&D at Pepex Biomedical (St. Louis, MO). Pepex is an early stage medical device company specializing in developing, manufacturing and marketing disposable miniaturized electrochemical biosensors.
Earlier in his career, Dr. Vreeke held research positions at TheraSense. At TheraSense he contributed to the successful transfer of glucose sensor technology from the University of Texas. This was one of the most profitable technology transfer plays for any university outside of the drug space. The company was originally funded through the SBIR program and can be counted as one of the SBIR program’s biggest successes.
He graduated from Calvin College with a BS in chemistry and went on to receive a PhD in analytical chemistry from the University of Texas at Austin. He is currently a member of the editorial advisory board of IVD Technology and is a visiting professor in the chemical engineering department at the Universitat Rovira i Virgili (Tarragona, Spain). He sits on several academic, industry, and corporate boards. Academic honors include a Dow Scholar, Welch Fellow and Woodrow Wilson Fellow.
Mark is attending / has attended:
VSVC West 2021
Venture Summit Virtual Connect 21